Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.92% | 158.01 | 0.7% | $1348.71m | |
| PFE | Pfizer Inc. | -0.89% | 33.52 | 0.9% | $1215.71m | |
| BMY | Bristol-Myers Squibb Co. | -1.35% | 61.26 | 1.0% | $862.91m | |
| MRK | Merck & Co., Inc. | -2.73% | 72.58 | 0.7% | $818.60m | |
| ABBV | AbbVie, Inc. | 0.28% | 107.63 | 1.9% | $796.41m | |
| LLY | Eli Lilly & Co. | 0.43% | 204.69 | 1.1% | $749.41m | |
| AZN | AstraZeneca Plc | -1.08% | 48.38 | 1.2% | $499.92m | |
| GSK | GlaxoSmithKline Plc | -2.24% | 33.61 | 0.2% | $268.95m | |
| NVS | Novartis AG | -0.87% | 85.96 | 0.2% | $176.78m | |
| SNY | Sanofi | 0.20% | 45.89 | 0.2% | $170.59m | |
| VTRS | Viatris, Inc. | -1.33% | 14.85 | 0.0% | $143.27m | |
| VERU | Veru, Inc. | -3.22% | 13.82 | 0.0% | $113.90m | |
| CVAC | CureVac NV | 1.43% | 94.30 | 0.0% | $107.31m | |
| NVO | Novo Nordisk A/S | -1.47% | 71.28 | 0.1% | $90.64m | |
| VYNE | VYNE Therapeutics, Inc. | -5.45% | 7.46 | 0.0% | $88.66m |
Company Profile
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.